These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 37890335)
21. Cytochrome oxidase deficiency in Wilson's disease: a suggested ceruloplasmin function. Shokeir MH; Shreffler DC Proc Natl Acad Sci U S A; 1969 Mar; 62(3):867-72. PubMed ID: 4308098 [TBL] [Abstract][Full Text] [Related]
22. Wilson's disease: presymptomatic patients and Kayser-Fleischer rings. Rodman R; Burnstine M; Esmaeli B; Sugar A; Martonyi C; Johnson V; Brewer G Ophthalmic Genet; 1997 Jun; 18(2):79-85. PubMed ID: 9228244 [TBL] [Abstract][Full Text] [Related]
23. Intracellular distribution of the Wilson's disease gene product (ATPase7B) after in vitro and in vivo exogenous expression in hepatocytes from the LEC rat, an animal model of Wilson's disease. Nagano K; Nakamura K; Urakami KI; Umeyama K; Uchiyama H; Koiwai K; Hattori S; Yamamoto T; Matsuda I; Endo F Hepatology; 1998 Mar; 27(3):799-807. PubMed ID: 9500710 [TBL] [Abstract][Full Text] [Related]
24. The diagnosis of Wilson's disease in asymptomatic patients. STERNLIEB I; SCHEINBERG IH JAMA; 1963 Mar; 183():747-50. PubMed ID: 13983986 [No Abstract] [Full Text] [Related]
25. [COPPER METABOLISM AND WILSON'S DISEASE]. LANGE J Verh Dtsch Ges Inn Med; 1964; 70():330-7. PubMed ID: 14294237 [No Abstract] [Full Text] [Related]
26. Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease. Li Y; Togashi Y; Sato S; Emoto T; Kang JH; Takeichi N; Kobayashi H; Kojima Y; Une Y; Uchino J J Clin Invest; 1991 May; 87(5):1858-61. PubMed ID: 2022751 [TBL] [Abstract][Full Text] [Related]
27. Wilson's disease patients with normal ceruloplasmin levels. Yüce A; Koçak N; Ozen H; Gürakan F Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682 [TBL] [Abstract][Full Text] [Related]
28. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease. SCHEINBERG IH; MORELL AG J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081 [No Abstract] [Full Text] [Related]
29. [Kayser-Fleischer ring in Wilson's disease]. Hajare Q; Mehdi K Pan Afr Med J; 2018; 30():137. PubMed ID: 30374383 [TBL] [Abstract][Full Text] [Related]
31. Characteristics of neurological Wilson's disease without Kayser-Fleischer ring. Youn J; Kim JS; Kim HT; Lee JY; Lee PH; Ki CS; Cho JW J Neurol Sci; 2012 Dec; 323(1-2):183-6. PubMed ID: 23043908 [TBL] [Abstract][Full Text] [Related]
32. Observations on copper metabolism in Wilson's disease. Czlonkowska A; Galewicz A; Rodo M; Wehr H Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768 [No Abstract] [Full Text] [Related]
33. Metabolic aspects of Wilson's disease: a review. SIMPSON JF Med Bull (Ann Arbor); 1963; 29():145-54. PubMed ID: 13977562 [No Abstract] [Full Text] [Related]
34. Copper disposition of the fetus and placenta in a patient with untreated Wilson's disease. Oga M; Matsui N; Anai T; Yoshimatsu J; Inoue I; Miyakawa I Am J Obstet Gynecol; 1993 Jul; 169(1):196-8. PubMed ID: 8333453 [TBL] [Abstract][Full Text] [Related]
35. Plasma and erythrocyte copper, zinc, manganese and magnesium concentrations in Wilson's disease. Goto I; Kawano Y; Tsuchiya T; Tamagawa Y; Kuroiwa Y Clin Neurol Neurosurg; 1986; 88(3):193-6. PubMed ID: 3780108 [TBL] [Abstract][Full Text] [Related]
40. Defective copper binding to apo-ceruloplasmin in a rat model and patients with Wilson's disease. Kojimahara N; Nakabayashi H; Shikata T; Esumi M Liver; 1995 Jun; 15(3):135-42. PubMed ID: 7674840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]